{"status":"OK","data":{"advertisement":{"id":203930,"title":"ZAPYTANIE OFERTOWE NR 23/2023/G/STEP7","partial_offer_allowed":false,"publication_date":"2023-04-21","submission_deadline":"2023-05-02 23:59:59","planned_sign_date":"2023-05-01","supplementary_orders":null,"terms_of_contract_change":null,"created_at":"2023-04-21 11:34:11","modified_at":"2023-05-03 00:00:03","contact_persons":[{"id":64,"forename":"Paulina","surname":"Gruszka","phone_number":"","email":"paulina.gruszka@celonpharma.com","created_by":null,"created_at":"2025-05-14 12:08:24","modified_at":"2025-05-14 12:08:24","modified_by":null}],"orders":[{"id":337000,"estimated_value":null,"order_items":[{"id":382040,"description":"Podwykonawstwo: Wyzanczenie warto\u015bci EC50/IC50 w do\u015bwiadczeniach funkcjonalnych dla 1 zwi\u0105zku\n\u2022\tBadanie s\u0142u\u017cy wyznaczneiu warto\u015bci EC50/IC50, w zale\u017cno\u015bci od do\u015bwiadczenia, w nast\u0119puj\u0105cych eksperymentach opartych liniach kom\u00f3rkowych z odczytem funkcjonalnym: \no\tDo\u015bwiadczenie wykazuj\u0105ce w\u0142a\u015bciwo\u015bci antagonistyczne wobec ludzkiego receptora adrenergicznego alpha1A \no\tDo\u015bwiadczenie wykazuj\u0105ce w\u0142a\u015bciwo\u015bci antagonistyczne wobec ludzkiego transportera dopaminy\no\tDo\u015bwiadczenie wykazuj\u0105ce w\u0142a\u015bciwo\u015bci antagonistyczne wobec ludzkiego receptora serotoninowego 5-HT2B \no\tDo\u015bwiadczenie wykazuj\u0105ce w\u0142a\u015bciwo\u015bci agonistyczne wobec ludzkiego receptora serotoninowego 5-HT2B \no\tDo\u015bwiadczenie wykazuj\u0105ce w\u0142a\u015bciwo\u015bci antagonistyczne wobec ludzkiego receptora adrenergicznego 5-HT2C\n\u2022\tDo\u015bwiadczenia powinny by\u0107 wykonane dla 8 st\u0119\u017ce\u0144 w duplikatach.\n\u2022\tBadania powinny gwarantowa\u0107 wyniki o du\u017cej stabilno\u015bci i powtarzalno\u015bci.\n\u2022\tPanel lub raport powinien zawiera\u0107 wyniki dla kontroli do\u015bwiadcze\u0144.\n\u2022\tWyniki powinny zosta\u0107 przedstawione w szczeg\u00f3\u0142owym raporcie, zawiera\u0107 opis metod oraz odczyty/wyniki z ka\u017cdej powt\u00f3rki eksperymentu.","warranty_period":null,"cpv_items":[{"id":8513,"code":"73100000-3","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":"mazowieckie","poviat":"nowodworski","commune":"Czosn\u00f3w","locality":"Kazu\u0144 Nowy","created_by":null,"created_at":"2023-04-21 11:34:11","modified_at":"2023-04-21 11:34:11","modified_by":null,"id":430244,"type":{"id":1,"name":"adres"},"group_uuid":"a91c296a-0b81-4708-9832-f416a5689f38"}],"participation_conditions":[],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2023-04-21 11:34:11","modified_at":"2023-04-21 11:34:11","modified_by":null,"group_uuid":"1aaa661c-fddd-4fbd-af40-61d69103fe0c"}],"evaluation_criteria":[{"id":585163,"price_criterion":true,"description":"Cena \u201eP\u201d \u2013 maks. 80 punkt\u00f3w (80% punkt\u00f3w mo\u017cliwych do zdobycia)","created_by":null,"created_at":"2023-04-21 11:34:11","modified_at":"2023-04-21 11:34:11","modified_by":null,"group_uuid":"433c20e5-9380-4e8c-a548-88939f3079b3"},{"id":585164,"price_criterion":false,"description":"Czas \u201eT\u201d \u2013 maks. 20 punkt\u00f3w (20% punkt\u00f3w mo\u017cliwych do zdobycia)","created_by":null,"created_at":"2023-04-21 11:34:11","modified_at":"2023-04-21 11:34:11","modified_by":null,"group_uuid":"87383b3b-8b9d-40bf-93bd-e584acaeec11"}],"is_variant":false,"title":"Przeprowadzenie badania ","order_node":{"id":256440},"created_by":null,"created_at":"2023-04-21 11:34:11","modified_at":"2023-04-21 11:34:11","modified_by":null}],"created_by":{"id":177,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Celon Pharma S.A.","identification_number_type":"nip","identification_number":"1181642061","address":{"country":"Polska","voivodeship":"mazowieckie","poviat":"warszawski zachodni","commune":"\u0141omianki","locality":"Kie\u0142pin","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":531487,"street":"Ogrodowa ","number_description":"2A","postcode":"05-092"},"created_by":{"id":177,"contact_persons":[]},"created_at":"2023-04-21 11:34:11","modified_at":"2023-04-21 11:34:11","modified_by":{"id":177,"contact_persons":[]},"id":204401},"advertisement":{"id":155662,"number":"2023-177-155662","publication_date":"2023-04-21","created_by":{"id":177,"contact_persons":[]},"created_at":"2023-04-21 11:34:11","modified_at":"2023-05-03 00:00:03","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[203930],"enrollment":null,"projects":[{"id":656,"name":"Serotoninergiczna terapia przeciwb\u00f3lowa oparta o agonist\u0119 receptora 5-HT7 (STEP7)","number":"0887/19","activity":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"region":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2022-02-10 21:45:42","modified_at":"2022-02-10 21:45:42","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"institution":null,"full_number":"POIR.01.01.01-00-0887/19","perspective":{},"programme":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"priority":{"created_by":{"modified_by":null,"id":1,"contact_persons":[]},"created_at":"2020-08-17 19:00:00","modified_at":"2020-08-17 19:00:00","modified_by":{"modified_by":null,"id":1,"contact_persons":[]}},"type":"project","created_by":{"id":177,"contact_persons":[]},"created_at":"2020-08-19 14:14:32","modified_at":"2020-08-19 14:14:32","modified_by":{"id":177,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":203930,"publication_date":"2023-04-21"},"id":982693,"name":"Zapytanie ofertowe","file":{"id":1095314,"name":"ZO_23_2023_G_STEP7.pdf","created_at":"2023-04-21 11:33:46","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1095314"},"group_uuid":"f246f20e-5a0d-4bf0-b991-495d28a0c6ce"},{"origin":{"id":203930,"publication_date":"2023-04-21"},"id":982694,"name":"O\u015bwiadczenie","file":{"id":1095315,"name":"zal. 1 Oswiadczenie o braku powiazan.pdf","created_at":"2023-04-21 11:33:55","created_by":{"forename":"Paulina","surname":"Gruszka"},"uri":"/api/files/1095315"},"group_uuid":"55453b05-92a0-4f05-b3b4-beba6c3220ba"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}